Stay updated on Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.9%
    Check dated 2025-07-04T04:13:50.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    0.7%
    Check dated 2025-06-19T20:08:31.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:25:16.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T06:08:11.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.15.0 to v2.15.2 and removed several past dates, indicating a refresh of content and possibly new features or fixes. The removal of older dates suggests a focus on more current information.
    Difference
    0.8%
    Check dated 2025-04-30T14:18:58.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about a clinical trial involving nivolumab and trametinib for treating metastatic melanoma, while significant details about the trial's objectives and treatment protocols have been removed.
    Difference
    48%
    Check dated 2025-04-16T10:18:40.000Z thumbnail image

Stay in the know with updates to Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.